UN9

N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE


View summary at Ligand Expo



Chemical Component Summary

NameN-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE
Identifiers2-[(1-chloro-4-hydroxy-isoquinolin-3-yl)carbonylamino]ethanoic acid
FormulaC12 H9 Cl N2 O4
Molecular Weight280.66
TypeNON-POLYMER
Isomeric SMILESOC(=O)CNC(=O)c1nc(Cl)c2ccccc2c1O
InChIInChI=1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17)
InChIKeyOUQVKRKGTAUJQA-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count0
Bond Count29
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB08687 
NameFG-2216
Groupsinvestigational
DescriptionA orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability. [A14422]
Synonyms
  • 1-Chloro-N- (hydroxyformylmethyl-4-hydroxyisoquinoline-3-carboxamide
  • (((1-Chloro-4-hydroxyisoquinolin-3-yl)carbonyl)amino)acetic acid
  • FG-2216
  • 1-Chloro-N-(hydroxyformylmethyl-4-hydroxyisoquinoline-3-carboxamide
IndicationInvestigated for use/treatment in anemia and kidney disease.
CAS number223387-75-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Egl nine homolog 1MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQD...unknown
Hypoxia-inducible factor 1-alphaMEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682